Where is Jeito headquartered?

Jeito is headquartered in Paris, France.

What is Jeito's total asset value?

Jeito has around in total assets under management.

What has Jeito invested in?

Jeito has made numerous investments in companies like Bionyra , Adcendo , and Alveus Therapeutics within the Drug Discovery industry.

What has Jeito invested in recently?

Jeito's latest investment was on 22-Jun-2026 in Bionyra , a company within the Drug Discovery industry.

Jeito investment portfolio

Jeito Overview

Investor Type

Growth/Expansion

Status

Active

Professionals

12

Investments

32

Portfolio

19

Exits

6

Jeito General Information

Company Description

Founded in 2018, Jeito is a growth equity firm based in Paris, France. The firm seeks to invest in biotech and innovative medical companies.

Business Details

Website

www.jeito.life

Year Founded

2018

Investor Status

Actively Seeking New Investments

Trade Association

French Venture Capital Association (AFIC)

Principles for Responsible Investment (PRI)

Primary Investor Type

Growth/Expansion

Other Investor Types

Other Private Equity

Corporate Office

37 rue de la Victoire
75009 Paris
France





Jeito Investments (32)

Jeito’s most recent investment was a with Bionyra for . The deal was made on 22-Jun-2026 with as the lead partner.

Company Name	Deal Date	Deal Type	Industry	Company Stage
Bionyra	22-Jun-2026		Drug Discovery	Pre-Clinical Trials
Adcendo	14-Apr-2026		Drug Discovery	Pre-Clinical Trials
Alveus Therapeutics	24-Feb-2026		Drug Discovery	Clinical Trials - Phase 2
Pulmocide	23-Sep-2025		Drug Discovery	Clinical Trials - Phase 3
Odyssey Therapeutics	10-Sep-2025	Later Stage VC	Biotechnology	Generating Revenue

You’re viewing 5 of 32 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jeito Exits (6)

Jeito has made a total of 6 exits. Its latest exit was from Odyssey Therapeutics for on 07-May-2026. The exit was categorized as .

Company Name	Exit Date	Exit Type
Odyssey Therapeutics	07-May-2026
Precirix	20-Jan-2026
EyeBio	10-Jul-2024
HI-Bio	02-Jul-2024
Neogene Therapeutics	16-Jan-2023	Merger/Acquisition

You’re viewing 5 of 6 exits. Get the full list »

Jeito Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.